Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPhase III Study Showed Two Years of ACTEMRA Inhibited Progression of Joint Damage and Improved Disease Remission
Genentech, 10/19/09
Genentech, Inc., a wholly–owned member of the Roche Group, announced two–year results from a Phase III study, which showed that people with rheumatoid arthritis who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA, in combination with methotrexate, had no progression of joint damage, compared with people who received methotrexate alone. The overall safety profile of ACTEMRA was consistent across all global clinical studies.
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin
Central European Journal of Medicine, 11/24/09
Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients
Journal of Anesthesia, 11/24/09
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: A prospective, randomised study comparing two doses of parnaparin (BAFLUX STUDY)
Thrombosis Research, 11/24/09
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
A Multicenter, Double-Blind, Randomized, Parallel Group Study Comparing Polyvinyl Chloride and Polyvinyl Chloride-Free Catheter Materials
The Journal of Urology, 11/24/09
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Anticancer Research, 11/16/09
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkins Lymphoma
Cephalon, 11/06/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/24/09
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
DPP-4 Inhibitors in Clinical Practice
Postgraduate Medicine, 11/24/09
Sponsor
Article Search
Sponsor